IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY);KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
SIM, TAE BO,심태보,HUR, WOO YOUNG,허우영,YOON, HO JONG,윤호종,SONG, CHI MAN,송치만,SHUN, IN JAE,신인재,LIM, BYEONG YUN,임병윤,CHO, HAN NA,조한나,CHOI, SEUNG HYE,최승혜,KONG, GU,공구,LEE, JEONG YEON,이정연
申请号：
KR1020160038606
公开号：
KR1017252920000B1
申请日:
2016.03.30
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to a novel pyrimidine-4-carboxylic acid derivative having anticancer activity. The compound of the present invention can be useful as a medicine for treating and preventing oncologic disorders. The compound of the present invention is selected from a pyrimidine-4-carboxylic acid compound represented by chemical formula 1, a hydrate thereof, a solvate thereof, an isomer thereof, a racemate thereof, or a pharmaceutically acceptable salt thereof.본 발명은 항암 활성을 갖는 신규 피리미딘-4-카르복시산 유도체에 관한 것이며, 본 발명의 화합물은 종양 질환의 치료 및 예방용 약제로 유용하다.
